Literature DB >> 2565359

The influence of repeated treatment with imipramine, (+)- and (-)-oxaprotiline on behavioural effects of dopamine D-1 and D-2 agonists.

J Maj1, M Papp, G Skuza, K Bigajska, M Zazula.   

Abstract

The paper examined the action of imipramine, (+)- and (-)-oxaprotiline, administered repeatedly to rats, on the behavioural effects of the dopamine D-1 and D-2 agonists, SKF 38393 and quinpirole, respectively. The three antidepressants studied, given in the single dose or repeatedly, attenuate the enhanced grooming evoked by SKF 38393. The locomotor hyperactivity, evoked by quinpirole administered s.c., is increased by repeated but not single-dose treatment with imipramine and (+)-oxaprotiline [but not with (-)-oxaprotiline]. Quinpirole at a low dose produces the locomotor hypoactivity which is attenuated by repeated, but not single-dose, treatment with the anti-depressants studied here. Repeated imipramine and (+)-oxaprotiline [but not (-)-oxaprotiline] increase the locomotor activity effect of quinpirole injected into the nucleus accumbens. The results indicate that the enhanced responsiveness of the dopamine system, observed previously after repeated treatment with antidepressants, may be mediated by the dopamine D-2 receptors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2565359     DOI: 10.1007/BF01244989

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  24 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  Prenatal exposure of rats to antidepressants enhances agonist affinity of brain dopamine receptors and dopamine-mediated behaviour.

Authors:  M L De Ceballos; A Benedi; C De Felipe; J Del Rio
Journal:  Eur J Pharmacol       Date:  1985-10-22       Impact factor: 4.432

Review 3.  Brain dopamine receptors.

Authors:  P Seeman
Journal:  Pharmacol Rev       Date:  1980-09       Impact factor: 25.468

4.  Repeated treatment with imipramine decreased the number of [3H]piflutixol binding sites in the rat striatum.

Authors:  V Klimek; M Nielsen; J Maj
Journal:  Eur J Pharmacol       Date:  1985-02-12       Impact factor: 4.432

5.  Repeated treatment with imipramine or amitriptyline increases the locomotor response of rats to (+)-amphetamine given into the nucleus accumbens.

Authors:  J Maj; K Wedzony
Journal:  J Pharm Pharmacol       Date:  1985-05       Impact factor: 3.765

6.  Increased intracranial self-stimulation in rats after long-term administration of desipramine.

Authors:  H C Fibiger; A G Phillips
Journal:  Science       Date:  1981-11-06       Impact factor: 47.728

7.  The influence of oxaprotiline enantiomers given repeatedly on the behavioural effects of d-amphetamine and dopamine injected into the nucleus accumbens.

Authors:  J Maj; K Wedzony
Journal:  Eur J Pharmacol       Date:  1988-01-12       Impact factor: 4.432

8.  6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.

Authors:  G R Breese; G E Duncan; T C Napier; S C Bondy; L C Iorio; R A Mueller
Journal:  J Pharmacol Exp Ther       Date:  1987-01       Impact factor: 4.030

9.  Chronic treatment with antidepressants decreases the number of [3H]SCH 23390 binding sites in the rat striatum and limbic system.

Authors:  V Klimek; M Nielsen
Journal:  Eur J Pharmacol       Date:  1987-07-09       Impact factor: 4.432

10.  Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions.

Authors:  J Arnt; J Hyttel; K F Overø
Journal:  Pol J Pharmacol Pharm       Date:  1984 Mar-Jun
View more
  7 in total

1.  Antidepressants given repeatedly increase the behavioural effect of dopamine D-2 agonist.

Authors:  J Maj; Z Rogóz; G Skuza; H Sowińska
Journal:  J Neural Transm Gen Sect       Date:  1989

2.  Repeated administration of antidepressant drugs affects the levels of mRNA coding for D1 and D2 dopamine receptors in the rat brain.

Authors:  M Dziedzicka-Wasylewska; R Rogoz; V Klimek; J Maj
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine.

Authors:  M Papp; V Klimek; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

4.  A novel mechanism of cocaine to enhance dopamine d2-like receptor mediated neurochemical and behavioral effects. An in vivo and in vitro study.

Authors:  Luca Ferraro; Malgorzata Frankowska; Daniel Marcellino; Magdalena Zaniewska; Sarah Beggiato; Malgorzata Filip; Maria Cristina Tomasini; Tiziana Antonelli; Sergio Tanganelli; Kjell Fuxe
Journal:  Neuropsychopharmacology       Date:  2012-03-28       Impact factor: 7.853

5.  Antidepressant response to aripiprazole augmentation associated with enhanced FDOPA utilization in striatum: a preliminary PET study.

Authors:  Charles R Conway; John T Chibnall; Paul Cumming; Mark A Mintun; Marie Anne I Gebara; Dana C Perantie; Joseph L Price; Martha E Cornell; Jonathan E McConathy; Sunil Gangwani; Yvette I Sheline
Journal:  Psychiatry Res       Date:  2014-01-14       Impact factor: 3.222

6.  The effect of (+)- and (-)-oxaprotiline administered repeatedly on the dopamine system.

Authors:  J Maj; V Klimek; Z Rogóz; G Skuza; H Sowińska
Journal:  J Neural Transm Gen Sect       Date:  1991

7.  Desmethylimipramine attenuates cocaine withdrawal in rats.

Authors:  A Markou; R L Hauger; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.